| Literature DB >> 27536511 |
Ann Marie Flores1, Jason Nelson2, Lee Sowles3, Karen Bienenstock1, William J Blot4.
Abstract
PURPOSE: We describe impairments after breast cancer and its treatment for African American (AA), non-Hispanic white and low-income breast cancer survivors (BCS) and whether physical therapy (PT) was utilized to address these impairments.Entities:
Keywords: Breast cancer; Impairments; Income; Physical therapy; Race
Year: 2016 PMID: 27536511 PMCID: PMC4971004 DOI: 10.1186/s40064-016-2455-3
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Characteristics by race and income
| Characteristica | Overall | Race | P valueb | Income | P valuec | ||||
|---|---|---|---|---|---|---|---|---|---|
| White | AA | ≤$10 k | $10,001–$20,000 | $20,001–$40,000 | ≥$40,000 | ||||
| Age (years), mean | 63.7 | 64.9 | 62.2 | 0.0002 | 63.3 | 64.6 | 64.7 | 61.2 | 0.0017 |
| Education (%) | |||||||||
| <High school | 17.7 | 15.5 | 17.9 | 0.79 | 37.3 | 19.8 | 11.0 | 0.0 | <0.0001 |
| High school | 27.9 | 29.4 | 27.2 | 29.7 | 39.7 | 30.1 | 13.0 | ||
| Some College/vocational training | 29.4 | 27.6 | 30.4 | 26.3 | 29.4 | 36.0 | 26.8 | ||
| College graduate | 13.7 | 14.7 | 14.0 | 4.2 | 8.7 | 12.5 | 29.0 | ||
| Graduate school | 11.4 | 12.8 | 10.5 | 2.5 | 9.6 | 9.6 | 31.2 | ||
| Missing/refuse | 1.0 | 0.4 | 1.9 | 0.8 | 2.3 | 0.7 | 0.7 | ||
| No. of years since BC diagnosis, mean | 12.6 | 12.7 | 12.5 | 0.74 | 13.4 | 13.4 | 12.5 | 11.3 | 0.073 |
| BMI, mean | 31.2 | 29.5 | 32.9 | <0.0001 | 32.5 | 31.9 | 31.0 | 29.2 | 0.0014 |
| % Incomec | |||||||||
| <$10 K | 22.7 | 29.0 | 33.3 | <0.0001 | – | – | – | – | – |
| $10 K–$20 K | 24.6 | 24.7 | 24.7 | – | – | – | – | – | |
| $20 K–$40 K | 26.2 | 30.5 | 22.4 | – | – | – | – | – | |
| >$40 K | 26.5 | 33.6 | 19.6 | – | – | – | – | – | |
| Raceb | |||||||||
| White | – | – | – | – | 11.2 | 24.7 | 30.5 | 33.6 | <0.0001 |
| AA | – | – | – | 33.3 | 24.7 | 22.4 | 19.6 | ||
| Enrollment location (%) | |||||||||
| Community health center | 58.6 | 54.1 | 60.7 | 0.13 | 75.6 | 71.3 | 51.1 | 35.3 | <0.0001 |
| Public recruitment | 41.4 | 45.9 | 39.3 | 24.4 | 28.7 | 48.9 | 64.8 | ||
| Insurance (%)* | |||||||||
| Medicaid | 17.3 | 11.3 | 22.5 | 0.0006 | 52.1 | 14.1 | 5.8 | 0.7 | <0.0001 |
| Medicare | 54.8 | 57.1 | 52.7 | 0.30 | 58.8 | 70.5 | 55.5 | 36.7 | <0.0001 |
| Private | 53.5 | 60.2 | 47.7 | 0.0041 | 18.5 | 36.4 | 67.2 | 86.3 | <0.0001 |
| Champus | 4.5 | 4.9 | 4.2 | 0.70 | 0.8 | 1.6 | 6.6 | 7.2 | 0.0036 |
| Other | 9.3 | 10.2 | 8.8 | 0.59 | 8.4 | 10.9 | 11.0 | 7.2 | 0.56 |
| None | 8.0 | 7.5 | 7.3 | 0.90 | 10.1 | 10.1 | 11.0 | 0.7 | 0.0021 |
| Missing/refuse | 6.8 | 0 | 0 | – | 52.1 | 14.1 | 5.8 | 0.7 | <0.0001 |
| BC treatment (%) | |||||||||
| Any surgery | 98.4 | 98.5 | 98.9 | 0.72 | 99.2 | 100.0 | 97.8 | 97.8 | 0.18 |
| Mastectomy | 60.5 | 61.1 | 61.0 | 0.99 | 68.6 | 65.9 | 59.0 | 50.7 | 0.0014 |
| Lumpectomy | 46.4 | 48.9 | 43.2 | 0.20 | 33.1 | 41.9 | 50.0 | 58.8 | <0.0001 |
| Sentinel or axillary node dissection | 58.7 | 62.9 | 55.9 | 0.11 | 64.9 | 52.4 | 53.4 | 65.2 | 0.47 |
| Chemotherapy | 47.2 | 45.9 | 49.4 | 0.41 | 46.6 | 45.0 | 46.7 | 52.5 | 0.25 |
| Radiation | 47.4 | 47.7 | 48.7 | 0.83 | 40.2 | 41.1 | 48.5 | 60.4 | 0.0002 |
| Long term medication | 47.3 | 52.3 | 43.5 | 0.044 | 38.1 | 45.3 | 53.3 | 49.6 | 0.072 |
| No. of modalities mean (SD) | 3.2 (1.4) | 3.4 (1.5) | 3.2 (1.3) | 0.091 | 3.0 (1.2) | 3.1 (1.4) | 3.3 (1.4) | 3.6 (1.4) | 0.0042 |
| High blood pressure (%) | 53.9 | 39.8 | 68.3 | <0.0001 | 71.4 | 60.9 | 50.4 | 37.0 | <0.0001 |
| Myocardial Infarct (%) | 5.1 | 3.8 | 5.0 | 0.50 | 4.2 | 8.5 | 4.4 | 0.7 | 0.022 |
| Diabetes (%) | 25.8 | 16.2 | 34.0 | <0.0001 | 37.0 | 33.3 | 19.0 | 13.7 | <0.0001 |
| Stroke (%) | 4.5 | 4.1 | 4.6 | 0.80 | 7.6 | 8.5 | 0.7 | 2.2 | 0.0037 |
| Hepatitis (%) | 2.1 | 1.1 | 3.4 | 0.076 | 5.9 | 1.6 | 1.5 | 0.7 | 0.028 |
| Emphysema (%) | 8.4 | 8.6 | 8.1 | 0.81 | 17.6 | 7.0 | 6.6 | 4.3 | 0.0008 |
| Depression (%) | 23.0 | 25.2 | 21.4 | 0.30 | 40.3 | 27.1 | 16.1 | 12.9 | <0.0001 |
| Osteoarthritis (%) | 57.8 | 56.0 | 60.7 | 0.28 | 77.3 | 53.5 | 61.3 | 43.2 | <0.0001 |
| Menopause (%) | 96.0 | 98.5 | 93.9 | 0.0056 | 91.6 | 99.2 | 97.8 | 95.0 | <0.0001 |
aCongestive heart failure, HIV/AIDS, memory problems, paralysis, were excluded because they were not significant
bComparisons by race are independent samples t tests (continuous variables) and Chi square tests (categorical variables)
cDifferences between income groups are from ANOVA tests (continuous variables) and Chi square tests (categorical variables)
* Participants selected all applicable insurance types and combinations reported are: Medicaid + Medicare (n = 43), Medicaid + Medicare + Other (n = 13), Medicaid + Other (n = 8), and Medicare + Other (n = 152)
Percent impairments and PT by race
| Impairment | % impairment | % PT use | ||||
|---|---|---|---|---|---|---|
| AA %a | White %a | Adj. ORb,c (95 % CI) | AA %a | White %a | Adj. ORb,c (95 % CI) | |
| Shoulder | 34.7 | 29.8 | 0.97 (0.63, 1.50) | 42.9 | 25.3 | 2.56 (1.11, 5.90) |
| Muscle weakness | 39.6 | 38.8 | 0.65 (0.42, 1.00) | 27.2 | 18.6 | 2.43 (1.00, 5.87) |
| Pain | 47.3 | 42.1 | 0.85 (0.56, 1.30) | 23.4 | 12.5 | 3.16 (1.33, 7.50) |
| Fatigue | 56.5 | 58.6 | 0.64 (0.41, 0.99) | 5.4 | 5.8 | 1.00 (0.32, 3.19) |
| Skin numbness | 59.9 | 58.6 | 0.83 (0.54, 1.28) | 9.6 | 5.0 | 2.27 (0.77, 6.69) |
| Postural abnormality | 16.2 | 15.4 | 0.78 (0.44, 1.36) | 14.3 | 12.2 | 5.46 (0.52, 57.43) |
a% in race group where the denominators are: for AA, n = 262; whites n = 266
bWhite is reference group
cORs adjusted for age, income, recruitment location, years since BC diagnosis, comorbidity, BMI, BC treatment
Percent impairments and PT by income
| Impairment | Income | % impairment | % reporting PT by impairment | ||
|---|---|---|---|---|---|
| %a | Adj. OR (95 % CI)b | % | Adj. OR (95 % CI)b | ||
| Shoulder | |||||
| <$10 K | 42.0 | 1.48 (0.68–3.27) | 26.0 | 1.05 (0.25–4.39) | |
| $10 K–$20 K | 31.0 | 0.84 (0.43–1.63) | 47.5 | 2.70 (0.81–8.95) | |
| $20 K–$40 K | 27.2 | 0.88 (0.49–1.59) | 24.3 | 0.61 (0.19–1.93) | |
| >$40 K (ref) | 28.8 | 1 (ref) | 40.0 | 1 (ref) | |
| Muscle weakness | <$10 K | 54.6 | 2.21 (1.00–4.86) | 13.9 | 0.47 (0.09–2.33) |
| $10 K–$20 K | 42.2 | 1.44 (0.74–2.77) | 40.7 | 3.04 (0.82–11.32) | |
| $20 K–$40 K | 36.8 | 1.34 (0.75–2.41) | 18.0 | 1.07 (0.29–3.94) | |
| >$40 K (ref) | 27.9 | 1 (ref) | 18.4 | 1 (ref) | |
| Pain | <$10 K | 58.0 | 2.66 (1.23–5.76) | 11.6 | 0.40 (0.08–1.93) |
| $10 K–$20 K | 40.3 | 1.01 (0.54–1.89) | 32.7 | 1.94 (0.56–6.73) | |
| $20 K–$40 K | 45.3 | 1.53 (0.89–2.62) | 16.1 | 1.01 (0.33–3.16) | |
| >$40 K (ref) | 38.1 | 1 (ref) | 15.1 | 1 (ref) | |
| Fatigue | <$10 K | 64.7 | 1.49 (0.67–3.33) | 5.2 | 2.34 (0.16–35.13) |
| $10 K–$20 K | 57.8 | 0.94 (0.50–1.79) | 13.5 | 6.52 (0.64–66.02) | |
| $20 K–$40 K | 54.0 | 1.01 (0.58–1.75) | 2.7 | 1.98 (0.16–23.89) | |
| >$40 K (ref) | 54.4 | 1 (ref) | 1.3 | 1 (ref) | |
| Skin numbness | <$10 K | 63.9 | 1.71 (0.77–3.81) | 7.9 | 2.46 (0.34–17.92) |
| $10 K–$20 K | 55.8 | 0.78 (0.42–1.46) | 12.5 | 4.27 (0.90–20.41) | |
| $20 K–$40 K | 59.1 | 1.05 (0.60–1.83) | 4.9 | 1.23 (0.28–5.51) | |
| >$40 K (ref) | 62.6 | 1 (ref) | 5.8 | 1 (ref) | |
| Postural abnormality | <$10 K | 26.3 | 1.88 (0.67–5.31) | 16.1 | 1.57 (0.02–103.29) |
| $10 K–$20 K | 17.3 | 1.52 (0.63–3.71) | 13.6 | 0.42 (0.02–8.26) | |
| $20 K–$40 K | 11.0 | 1.03 (0.45–2.39) | 13.3 | 1.90 (0.07–51.69) | |
| >$40 K (ref) | 10.8 | 1 (ref) | 13.3 | 1 (ref) | |
a% income category where denominators are: ≤$10 k, n = 119; $10,001–$20,000, n = 129; $20,001–$40,000, n = 137; ≥$40,000, n = 139
bOdds ratios adjusted for age, race, recruitment location, years since BC diagnosis, comorbidity, BMI, BC treatment types